HomeHRTIS • HEL
add
Herantis Pharma Oyj
Previous close
€1.87
Day range
€1.82 - €1.91
Year range
€1.20 - €3.87
Market cap
50.09M EUR
Avg Volume
33.80K
P/E ratio
-
Dividend yield
-
Primary exchange
HEL
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.72M | 51.51% |
Net income | -1.71M | -51.80% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.60M | 21.67% |
Total assets | 2.67M | 3.75% |
Total liabilities | 4.36M | 54.74% |
Total equity | -1.69M | — |
Shares outstanding | 24.09M | — |
Price to book | -26.71 | — |
Return on assets | -161.17% | — |
Return on capital | 258.72% | — |
Cash Flow
Net change in cash
| (EUR) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -1.71M | -51.80% |
Cash from operations | -1.35M | 22.88% |
Cash from investing | 1.15M | 2,745,338.10% |
Cash from financing | 353.50K | -67.20% |
Net change in cash | 152.00K | 122.44% |
Free cash flow | -1.08M | -50.96% |
About
Founded
2008
Website
Employees
13
